Vincenzo Carnovale

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter survey.

Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter survey.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: November 21, 2025

Case Series on the Combined Therapy with Elexacaftor/Tezacaftor/Ivacaftor During Pregnancy in Women with Severe Cystic Fibrosis: A Retrospective Report from an Italian Centre.

Case Series on the Combined Therapy with Elexacaftor/Tezacaftor/Ivacaftor During Pregnancy in Women with Severe Cystic Fibrosis: A Retrospective Report from an Italian Centre.

Journal: Journal of clinical medicine

Published: August 21, 2025

Pulmonary Function Modulates Epigenetic Age in Subjects with Cystic Fibrosis.

Pulmonary Function Modulates Epigenetic Age in Subjects with Cystic Fibrosis.

Journal: International journal of molecular sciences

Published: June 04, 2025

Blood platelet reduction after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis may depend on systemic inflammation reduction.

Blood platelet reduction after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis may depend on systemic inflammation reduction.

Journal: Scientific reports

Published: February 24, 2025

Effects of Oral Amino Acid Supplementation on Physical Activity, Systemic Inflammation, and Quality of Life in Adult Patients with Cystic Fibrosis: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Pilot Study.

Effects of Oral Amino Acid Supplementation on Physical Activity, Systemic Inflammation, and Quality of Life in Adult Patients with Cystic Fibrosis: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Pilot Study.

Journal: Nutrients

Published: February 16, 2025

Real-world effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Phe508del -gating and -residual function genotypes.

Real-world effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Phe508del -gating and -residual function genotypes.

Journal: Respiratory medicine

Published: December 08, 2024

Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment.

Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment.

Journal: Frontiers in medicine

Published: October 01, 2024

Metabolomic profiling of saliva from cystic fibrosis patients.

Metabolomic profiling of saliva from cystic fibrosis patients.

Journal: Scientific reports

Published: September 12, 2024

Beneficial economic effect of a virtual model of care for cystic fibrosis.

Beneficial economic effect of a virtual model of care for cystic fibrosis.

Journal: Pediatric pulmonology

Published: July 20, 2024

Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment.

Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment.

Journal: Scientific reports

Published: May 17, 2024

Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022

Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022

Journal: Epidemiologia e prevenzione

Published: May 14, 2024

Cystic Fibrosis in Adults: A Paradigm of Frailty Syndrome? An Observational Study.

Cystic Fibrosis in Adults: A Paradigm of Frailty Syndrome? An Observational Study.

Journal: Journal of clinical medicine

Published: November 13, 2023

Showing 1-12 of 56

Last Updated: 09/26/2026